<b>Conclusions:</b> These results demonstrate a novel pathway involving hsa_circ_0030042, eIF4A3, FOXO1, and beclin1; hence, modulating their levels may be a potential therapeutic strategy against CHD. This evidence concerns the gene FOXO1 and coronary artery disorder.